Munck Wilson Mandala’s Life Sciences industry group delivers strategic legal counsel tailored to the industry’s unique demands, backed by real-world experience. Our team includes litigators, patent prosecutors, and technical professionals with advanced degrees who are equipped to support companies across a wide range of biotech innovations, including small-molecule and biologic pharmaceuticals, medical devices, diagnostics, imaging systems, and emerging AI-driven medtech.

We represent domestic and international clients in actions brought in federal district and appellate courts, the USPTO, and the International Trade Commission. Our attorneys have handled numerous patent infringement cases under the Hatch-Waxman and Biologics Price Competition and Innovation Acts. We have also represented clients in cases relating to various medical and diagnostic devices, gene expression technologies, monoclonal antibodies, and fusion proteins.

We represent domestic and international clients in actions brought in federal district and appellate courts, the USPTO, and the International Trade Commission. Our attorneys have handled numerous patent infringement cases under the Hatch-Waxman and Biologics Price Competition and Innovation Acts. We have also represented clients in cases relating to various medical and diagnostic devices, gene expression technologies, monoclonal antibodies, and fusion proteins.

MWM regularly prosecutes patents for a wide range of biotechnology and life science innovations, whether it be AI-driven medtech, medical devices, pharmaceuticals, genetic sequencing technologies, or mRNA platforms. MWM’s prosecutors have advanced degrees in relevant fields and decades of prosecution experience. We also assist companies of all sizes with patent portfolio management and trademark matters, as well as technology transactions and corporate matters.

Our attorneys also guide clients navigating the Food and Drug Administration, Federal Trade Commission, and Office of Inspector General. Our team of professionals understands the challenges faced by researchers, scientists, and entrepreneurs. By combining deep industry knowledge with legal expertise, MWM provides guidance that helps organizations reach key milestones while navigating complex industry requirements

“We work with talented people and it’s remarkable to see how science and technology can improve the health and quality of people’s lives.  We appreciate having a law firm that understands entrepreneurs and the passion we have to make lives better.”

MWM client

Client Alerts

Federal Circuit revives a gene therapy patent, holding that the claimed technology is patent-eligible under Section 101

The case centers on U.S. Patent No. 10,526,617, which covers a human-made host cell containing a recombinant nucleic acid molecule created by splicing together genetic material from two different species. A Delaware district court had ruled the patent ineligible, finding it merely combined naturally occurring materials without meaningful modification. The Federal Circuit disagreed. In a

| less than a minute

Client Alerts

FDA Cracks Down on Compounded GLP-1 Advertising

By Merritt Westcott Background GLP-1 drugs were originally approved for diabetes but later gained separate FDA approvals for weight loss under new brand names and codes. These approvals allowed insurers to cover only the diabetes versions.  Both brands’ prices are near or above $1,000 per month. High demand led to FDA-declared shortages in 2022, allowing

| 2 minute read

Press Releases

Munck Wilson Mandala Names Merritt D. Westcott Chair of Firm’s Expanding Life Sciences Practice

Westcott has built her reputation as a go-to trial lawyer in high-stakes biotech and pharmaceutical patent disputes, representing clients across genetically engineered crops and food products, monoclonal antibodies, blood cell controls, MedTech devices, and both traditional and biosimilar pharmaceuticals under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act. “Merritt combines world-class legal

| 3 minute read

Press Releases

Munck Wilson Mandala welcomes life sciences partner Denise Mayfield

Mayfield focuses her practice on the drafting and prosecution of patents primarily in life science, chemistry, biotechnology, medical devices, and bio-electrical (sensor) technologies. She also creates and manages client patent portfolios, performs various due diligence services (pre- and post-litigation), prepares/negotiates technology licensing and other corporate agreements (collaborative research agreements, joint venture agreements, joint research and

| 2 minute read

Press Releases

Munck Wilson Mandala adds Partner and Scientific Advisor to Life Sciences Practice

Munck Wilson Mandala has added additional talent to its life sciences practice, offering a comprehensive legal solution for businesses at the forefront of biotechnology, pharmaceuticals, diagnostics and medical devices. The MWM life sciences group features a multidisciplinary team of attorneys and patent professionals with advanced degrees in genetics, molecular biology, chemistry, mechanical and electrical engineering,

| 2 minute read

Press Releases

Texas Lawyer Names William Munck a Texas Trailblazer

As a trailblazer, Munck was the first in his family to attend college and combined his computer science, electrical engineering, and mathematic skills with a law degree.  He was recruited heavily by Silicon Valley firms in the 90s but chose Texas to start his legal career.  Munck saw the potential that North Texas provided in

| 2 minute read